Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000232984 | SCV000288747 | uncertain significance | BAP1-related tumor predisposition syndrome | 2024-01-19 | criteria provided, single submitter | clinical testing | This sequence change replaces cysteine, which is neutral and slightly polar, with tyrosine, which is neutral and polar, at codon 649 of the BAP1 protein (p.Cys649Tyr). This variant is present in population databases (rs151308667, gnomAD 0.02%). This missense change has been observed in individual(s) with renal cell carcinoma (PMID: 24166983). ClinVar contains an entry for this variant (Variation ID: 240053). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt BAP1 protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change does not substantially affect BAP1 function (PMID: 33240524). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV000568347 | SCV000664603 | likely benign | Hereditary cancer-predisposing syndrome | 2023-02-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000568347 | SCV000902750 | likely benign | Hereditary cancer-predisposing syndrome | 2016-11-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001589192 | SCV001824688 | uncertain significance | not provided | 2023-10-04 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Published functional studies suggest no damaging effect: demonstrated nuclear localization and de-ubiquitination activity comparable to wild type (Hong et al., 2020); Observed in individuals with clear cell renal cell carcinoma or unspecified BAP1-related disease (Gossage et al., 2014; Zauderer et al., 2019); This variant is associated with the following publications: (PMID: 28873162, 33240524, 31323388, 24166983) |
Institute for Clinical Genetics, |
RCV001589192 | SCV002009772 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000568347 | SCV002537274 | likely benign | Hereditary cancer-predisposing syndrome | 2020-10-13 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV002267995 | SCV002550643 | uncertain significance | not specified | 2024-02-06 | criteria provided, single submitter | clinical testing |